What is the primary objective of **FDA 21 CFR Part 11**?

**The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the FDA considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures (§11.1(a)).** This equivalency enables electronic methods while ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls in closed (§11.10) and open (§11.30) systems, plus signature requirements (§§11.50–11.300).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or relied upon for regulated activities.** It covers life sciences firms (pharma, biotech, devices) maintaining such records in lieu of paper, submitting accepted electronic records to FDA (§11.1(b)), or using legally binding electronic signatures (§11.100). Paper-reliant systems are generally exempt if not relied upon electronically.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal validation, SOPs, training records, and inspection readiness (§11.1(e)), with systems and documentation available for FDA review. FDA's 2003 guidance emphasizes risk-based approaches and predicate rule enforcement over formal certification.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**Assessments for FDA 21 CFR Part 11 should be performed periodically as part of change control, system lifecycle reviews, and risk reassessments.** FDA guidance recommends ongoing monitoring via periodic reviews, with revalidation triggered by changes affecting accuracy, reliability, or integrity (§11.10(a),(k)). No fixed frequency is specified; align with predicate rules and business risks.

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA Form 483 observations, warning letters, product holds, recalls, or enforcement actions for predicate rule violations.** Even with enforcement discretion on some elements (validation, audit trails), failures in enforced controls (access, signatures) lead to data integrity issues, as seen in warning letters citing inadequate records and investigations.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**FDA 21 CFR Part 11 is not explicitly mapped to other frameworks in its text or 2003 guidance, which focuses solely on FDA predicate rules.** Organizations often align controls (e.g., audit trails, validation) with practices like GAMP 5 risk-based approaches for efficiency, but Part 11 compliance stands alone without formal crosswalks.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions.** Document scope decisions (e.g., in SOPs) per 2003 guidance: identify Part 11 records used in lieu of paper or for regulated activities, classify systems as closed/open, and prioritize risk-based controls.

Who is legally or professionally required to comply with **AS9100**?

**AS9100 applies professionally to organizations designing, developing, manufacturing, or servicing aviation, space, and defense products and services.** Major OEMs and primes require certification as a supplier qualification condition, with visibility via IAQG's OASIS database; it covers manufacturers, material suppliers, design centers, and quality organizations, but not distributors (AS9120) or MRO (AS9110).

Does **AS9100** require an external audit or third-party certification?

**Yes, AS9100 requires third-party certification through accredited bodies via a two-stage audit process.** Stage 1 assesses documentation and readiness; Stage 2 verifies implementation and effectiveness, using AS9101 guidance; certification is listed in OASIS, with annual surveillance audits and recertification every three years.

How often should an assessment for **AS9100** be performed?

**AS9100 requires internal audits at planned intervals per Clause 9.2, typically risk-based and covering all processes annually.** External surveillance audits occur annually, with full recertification every three years; management reviews (Clause 9.3) evaluate performance quarterly or as needed.

What are the consequences of non-compliance with **AS9100**?

**Non-compliance with AS9100 results in audit nonconformities, certification suspension or loss, and exclusion from OEM supply chains.** Major findings require corrective actions within 60–90 days, risking contract termination, OASIS delisting, and liability for safety incidents from poor configuration, counterfeit parts, or product safety failures.

Can **AS9100** be mapped to other international frameworks?

**Yes, AS9100D aligns directly with ISO 9001:2015 via its Annex SL 10-clause structure (Clauses 4–10), enabling integrated management systems.** It supports compatibility with standards sharing this framework through common elements like risk-based thinking (Clause 6.1), leadership (Clause 5), and performance evaluation (Clause 9).

What is the first step to begin implementing **AS9100**?

**The first step to implement AS9100 is conducting a gap analysis against AS9100D requirements, mapping current processes to Clauses 4–10.** Define QMS scope (Clause 4.3), identify internal/external issues and interested parties (4.1–4.2), and prioritize aerospace additions like operational risk (8.1.1) and supplier controls (8.4).

FDA 21 CFR Part 11 vs AS9100

Q: What is the primary objective of **AS9100**?

**AS9100's primary objective is to establish a quality management system (QMS) for aviation, space, and defense organizations that ensures product safety, configuration integrity, and supply chain reliability.** It builds on ISO 9001:2015 with over 100 aerospace-specific requirements, including Clause 8.1.2 configuration management, 8.1.3 product safety, and 8.1.4 counterfeit parts prevention, to mitigate catastrophic failure risks in high-consequence environments.

Standards Comparison

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

AS9100

Mandatory

2016

International standard for aerospace quality management systems.

Quick Verdict

FDA 21 CFR Part 11 mandates electronic records/signatures trustworthiness for life sciences, ensuring data integrity via validation and audit trails. AS9100 provides comprehensive QMS certification for aerospace, emphasizing safety, configuration, and supplier controls. Companies adopt Part 11 for FDA compliance; AS9100 for market access.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Establishes equivalency of electronic records to paper records
Mandates secure, time-stamped audit trails for changes
Requires unique electronic signatures with non-repudiation
Differentiates controls for closed versus open systems
Enforces validation and access limitation requirements

Quality Management

AS9100

AS9100D Quality Management Systems for Aerospace

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Configuration management for product integrity
Product safety processes across lifecycle
Counterfeit parts prevention controls
Operational risk management in Clause 8
Enhanced supplier evaluation and controls

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The approach is control-based with risk-based enforcement discretion per 2003 guidance, focusing on closed/open systems.

Key Components

Subparts A-C: scope, electronic records (§11.10/§11.30), signatures (§11.50-§11.300)
Core controls: validation, audit trails, access limits, authority checks, training, documentation
Principles: authenticity, integrity, non-repudiation; ~20 specific requirements
Compliance via risk-based validation, no formal certification but FDA inspection

Why Organizations Use It

Ensures data integrity for GxP compliance, avoids enforcement actions like warning letters. Drives efficiency in digital transformation, supports inspections, builds stakeholder trust, mitigates recalls/product holds.

Implementation Overview

Risk-based CSV (GAMP5): scoping, validation (IQ/OQ/PQ), SOPs/training, supplier governance. Applies to pharma/biotech/devices; multi-phase (6-24 months); ongoing audits/change control for life sciences firms.

AS9100 Details

What It Is

AS9100D (AS9100:2016) is the international quality management system (QMS) standard for aviation, space, and defense organizations. It builds on ISO 9001:2015 with over 100 aerospace-specific requirements, using a risk-based, process-oriented approach to ensure product safety and supply chain integrity.

Key Components

10-clause Annex SL structure covering context, leadership, planning, support, operation, evaluation, and improvement.
Aerospace additions: configuration management (8.1.2), product safety (8.1.3), counterfeit prevention (8.1.4), operational risks (8.1.1).
Built on PDCA cycle; requires certification via accredited third-party audits (Stage 1/2, surveillance).

Why Organizations Use It

**Market accessOften mandated by OEMs for supplier qualification.
**Risk reductionPrevents safety incidents, defects, counterfeit parts.
**BenefitsImproved delivery, cost savings, OASIS visibility.
Builds stakeholder trust in high-consequence industries.

Implementation Overview

Phased: gap analysis, process design, training, internal audits, certification (6-18 months).
Applies to manufacturers, designers, MROs globally; suits all sizes with scaled rigor.

Key Differences

Aspect	FDA 21 CFR Part 11	AS9100
Scope	Electronic records/signatures trustworthiness	Aerospace QMS with safety/traceability focus
Industry	FDA-regulated life sciences/pharma	Aviation, space, defense manufacturing
Nature	Mandatory US FDA regulation	Voluntary certification standard
Testing	Risk-based system validation/audit trails	Third-party audits, surveillance/recertification
Penalties	Warning letters, enforcement actions	Certification loss, market exclusion

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

AS9100

Aerospace QMS with safety/traceability focus

Industry

FDA 21 CFR Part 11

FDA-regulated life sciences/pharma

AS9100

Aviation, space, defense manufacturing

Nature

FDA 21 CFR Part 11

Mandatory US FDA regulation

AS9100

Voluntary certification standard

Testing

FDA 21 CFR Part 11

Risk-based system validation/audit trails

AS9100

Third-party audits, surveillance/recertification

Penalties

FDA 21 CFR Part 11

Warning letters, enforcement actions

AS9100

Certification loss, market exclusion

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and AS9100

FDA 21 CFR Part 11 FAQ

AS9100 FAQ

You Might also be Interested in These Articles...

DORA Third-Party Risk Management: A Consultant’s Guide to Mapping Critical ICT Service Providers in 2026

Navigate DORA's complex third-party risk pillar. Step-by-step consultant guide to identify critical ICT providers, remediate Article 30 contracts, and build the

Top 10 SOC 2 Audit Pitfalls and Fixes: Real Auditor Red Flags from Type 2 Fieldwork with Evidence Checklists

Discover 10 common SOC 2 Type 2 audit pitfalls like evidence gaps, scope creep, vendor oversights. Get Fail/Pass visuals, client stories, checklists for 95% fir

One Step at a Time - a 6 Month Plan to Live and Breath DORA

Achieve DORA compliance in 6 months with our detailed plan. Learn implementation sequence, starting steps, pitfalls to avoid, and accelerators for success. Toug

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

COBIT vs ISO 30301

Uncover COBIT vs ISO 30301: COBIT masters enterprise IT governance with 40 objectives & design factors; ISO 30301 certifies records systems for compliance. Align strategy now!

TOGAF vs SOX

Compare TOGAF vs SOX: Discover how TOGAF's ADM, governance, and ITGCs streamline SOX 404 compliance, ICFR testing, and enterprise risk management. Optimize now!

ISO 55001 vs AS9100

Compare ISO 55001 vs AS9100: Uncover key differences in asset management & aerospace quality. Integrate for risk control, compliance & lifecycle value. Optimize now!

FDA 21 CFR Part 11

AS9100

Quick Verdict

FDA 21 CFR Part 11

Key Features

AS9100

Key Features

Detailed Analysis

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

AS9100 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

AS9100 FAQ

What is the primary objective of AS9100?

Who is legally or professionally required to comply with AS9100?

Does AS9100 require an external audit or third-party certification?

How often should an assessment for AS9100 be performed?

What are the consequences of non-compliance with AS9100?

Can AS9100 be mapped to other international frameworks?

What is the first step to begin implementing AS9100?

You Might also be Interested in These Articles...

DORA Third-Party Risk Management: A Consultant’s Guide to Mapping Critical ICT Service Providers in 2026

Top 10 SOC 2 Audit Pitfalls and Fixes: Real Auditor Red Flags from Type 2 Fieldwork with Evidence Checklists

One Step at a Time - a 6 Month Plan to Live and Breath DORA

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

COBIT vs ISO 30301

TOGAF vs SOX

ISO 55001 vs AS9100